Schornstein Amends Stake in Assembly Biosciences

TL;DR

Schornstein filed a 13D/A for Assembly Biosciences, Inc. - check for changes in stake.

AI Summary

Alexander Schornstein filed an amendment (Amendment No. 3) to Schedule 13D on June 24, 2024, regarding Assembly Biosciences, Inc. The filing indicates a change in the reporting person's holdings or intentions concerning the company's common stock. Schornstein is located in Aachen, Germany.

Why It Matters

This amendment signals a potential shift in significant shareholder activity for Assembly Biosciences, Inc., which could influence stock price and corporate strategy.

Risk Assessment

Risk Level: medium — Schedule 13D filings often indicate significant changes in ownership or strategy by major shareholders, which can introduce volatility.

Key Players & Entities

• Alexander Schornstein (person) — Reporting Person
• Assembly Biosciences, Inc. (company) — Issuer
• 0001079973-24-000954 (filing_id) — Accession Number
• June 24, 2024 (date) — Filing Date

FAQ

From the Filing

0001079973-24-000954.txt : 20240624 0001079973-24-000954.hdr.sgml : 20240624 20240624162809 ACCESSION NUMBER: 0001079973-24-000954 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240624 DATE AS OF CHANGE: 20240624 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: ASSEMBLY BIOSCIENCES, INC. CENTRAL INDEX KEY: 0001426800 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-85836 FILM NUMBER: 241064682 BUSINESS ADDRESS: STREET 1: TWO TOWER PLACE STREET 2: 7TH FLOOR CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: (833) 409-4583 MAIL ADDRESS: STREET 1: TWO TOWER PLACE STREET 2: 7TH FLOOR CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: VENTRUS BIOSCIENCES INC DATE OF NAME CHANGE: 20080211 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Schornstein Alexander CENTRAL INDEX KEY: 0001999256 ORGANIZATION NAME: FILING VALUES: FORM TYPE: SC 13D/A MAIL ADDRESS: STREET 1: KAISER-FRIEDRICH-ALLEE 2 CITY: AACHEN STATE: 2M ZIP: 52074 SC 13D/A 1 schornstein_13da.htm SCHEDULE 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 Amendment No. 3 ASSEMBLY BIOSCIENCES, INC. (Name of Issuer) Common Stock, par value $0.001 (Title of Class of Securities) 0453961080 (CUSIP Number) Alexander Schornstein Kaiser-Friedrich-Allee 2, 52074 Aachen Germany 004915142314669 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) June 24, 2024 (Date of Event Which Requires Filing of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of § 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box [_]. Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See § 240.13d-7(b) for other parties to whom copies are to be sent. *The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“ Act ”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. 0453961080 1 NAME OF REPORTING PERSONS Alexander Schornstein 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions) (a) [ ] (b) [ ] 3 SEC USE ONLY 4 SOURCE OF FUNDS (See Instructions) PF 5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(D) OR 2(E) [ ] 6 CITIZENSHIP OR PLACE OF ORGANIZATION Germany NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 7 SOLE VOTING POWER 684,113 8 SHARED VOTING POWER 0 9 SOLE DISPOSITIVE POWER 684,113 10 SHARED DISPOSITIVE POWER 0 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 684,113 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See Instructions) [_] 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 10.78% (2) 14 TYPE OF REPORTING PERSON (See Instructions) IN (1) Includes 582,089 shares of Common Stock held by Alexander Schornstein and 92,024 shares of Common Stock held by Camino Capital GmbH, in which Alexander Schornstein is the sole beneficial owner and has sole voting power. (2) Based upon 6,345,561 shares of common stock of the Issuer issued and outstanding, w